drugset / Trial / NCT05675722

Implantation Of Vaginal Construct For Patients With Vaginal Aplasia

NCT05675722 ↗

Phase 1 Recruiting 10 enrolled Wake Forest University Health Sciences
NaSingle-groupOpen-labelTreatment

Summary

In this Phase 1, single site, clinical trial, Vulvar/vaginal Smooth muscle cells (SMC) and Epithelial Cells (EPC) are isolated from autologous patient's biopsy

Timeline

Start
2023-06-01
Primary completion
2029-12
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tissue Engineered Vagina Cell therapy — Other

Indications